ReposiTrak (NYSE:TRAK) CEO Randall Fields Sells 3,140 Shares

ReposiTrak Inc. (NYSE:TRAK) CEO Randall Fields sold 3,140 shares of the stock in a transaction dated Tuesday, October 14th. The stock was sold at an average price of $14.57, for a total value of $45,749.80. Following the transaction, the chief executive officer owned 46,860 shares of the company’s stock, valued at approximately $682,750.20. The trade was a 6.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

ReposiTrak Stock Performance

NYSE:TRAK opened at $14.29 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.09 and a current ratio of 6.09. The company has a market capitalization of $261.22 million, a P/E ratio of 40.83 and a beta of 0.44. ReposiTrak Inc. has a 52-week low of $13.86 and a 52-week high of $25.01. The stock’s 50-day moving average price is $16.25.

ReposiTrak (NYSE:TRAK) last posted its quarterly earnings results on Monday, September 29th. The company reported $0.09 earnings per share for the quarter. The firm had revenue of $5.76 million during the quarter. ReposiTrak had a return on equity of 14.25% and a net margin of 30.55%.

Institutional Trading of ReposiTrak

A number of hedge funds have recently made changes to their positions in the business. BNP Paribas Financial Markets lifted its position in shares of ReposiTrak by 63.5% in the second quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock valued at $32,000 after buying an additional 634 shares during the last quarter. Ingalls & Snyder LLC lifted its position in shares of ReposiTrak by 1.3% in the second quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company’s stock valued at $3,905,000 after buying an additional 2,554 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in shares of ReposiTrak by 397.3% in the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock valued at $71,000 after buying an additional 2,892 shares during the last quarter. Ellsworth Advisors LLC lifted its position in shares of ReposiTrak by 10.6% in the first quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company’s stock valued at $634,000 after buying an additional 2,997 shares during the last quarter. Finally, American Century Companies Inc. lifted its position in shares of ReposiTrak by 17.4% in the second quarter. American Century Companies Inc. now owns 23,344 shares of the company’s stock valued at $459,000 after buying an additional 3,455 shares during the last quarter. 27.35% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have weighed in on TRAK shares. Weiss Ratings restated a “hold (c+)” rating on shares of ReposiTrak in a research note on Wednesday, October 8th. Wall Street Zen downgraded ReposiTrak from a “buy” rating to a “hold” rating in a research note on Friday, October 3rd. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has a consensus rating of “Hold”.

ReposiTrak Company Profile

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.